Dr. Divya Bajpai 🇮🇳
@divyaa24
Prof Nephro KEM, ISOT Council, #NSMC faculty #Visualabstract creator. ISN-Emerging leader Women in Nephro I-Win Creator-monthly #Isneducation quizzes. Mom
ID:2933234910
17-12-2014 09:40:23
8,8K Tweets
8,1K Followers
1,3K Following
Relevant topics
Great discussions
Strong bonding
Had fun and got inspired at #isotmidterm
Thanks organizers 🙏🏼
What is Transplant oncology?
Dr John Fung explains using hepatocellupar carcinoma as prototype
#isotmidterm
.Vijay Kher sirs opinion on utility and futility of various induction agents in kidney transplant #ISOTMIDTERM
⚡ Normal waves in VEXUS
* S>D wave in hepatic vein
* <30% variation in PV
* flat negative venous wave in renal vein
⚡ Use IVC distensibility index in ventilated patients
⚡VTI change > 12% with fluid or leg raising is sign of fluid responsiveness
#ISOTMIDTERM
#ISOTMIDTERM started with a great lecture by Amit Pasari on volume assessment!
Key points
⚡Use combo of IVC USG, VEXUS & Echo for volume assessment
⚡indices may be different in Indians vs western data
⚡ Use USG with ur clinical acumen
⚡ Be friends with cardio & radio!
5/10
A figure paints 1000 words (or better have 2 figures, for a better overview)
Source of the second one ASN Kidney360 ncbi.nlm.nih.gov/pmc/articles/P…
9/10
I want more info
✅ Read about preeclampsia in this year #Nephmadness and the commentary by Andrea Oliverio on PE diagnosis
ajkdblog.org/2024/03/01/nep…
✅ #NephJC summary from Dr Kavita Vishwakarma Elba Medina
nephjc.com/news/praecis-p…
✅Visual abstract by Elba Medina Dr. Divya Bajpai 🇮🇳
How do you balance the
Risk🔥 vs Benefits ❤️
Of Deceased Donor Transplant with a active/historical malignancy in donor
❓do u hv pt where Benefit can outwei the Risks
Those who r have limited survival on dialysis anyways
Super excited for this session at #ISOTMIDTERM
A high- yield slide from Dr Geetika Singh at @glomcon today.
*Differences between 1ry vs 2ry MN*
and a very important message on
*how lupus membranous deceives us*